Drug development for breast (BC), colorectal (CRC), and non-small cell lung cancers (NSCLC) over the past 34 years.

e17789 Background: The purpose of this study was to delineate the drug development timeline and attrition rate of different drug classes for common cancer disease sites. Methods: A pharmaceutical b...